KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Long-Term Debt Repayments (2016 - 2025)

Exact Sciences (EXAS) has disclosed Long-Term Debt Repayments for 9 consecutive years, with $249.2 million as the latest value for Q1 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $249.2 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $249.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $249.2 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q1 2025 was $249.2 million at Exact Sciences, up from $150.1 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $249.2 million in Q1 2025, with the low at $249.2 million in Q1 2025.